Huntington's Disease Trial, Recruiting NCT06203106 Sponsor: New York Stem Cell Foundation Research Institute Condition: Huntington's Disease
Back to Huntingtons Disease

Huntington's Disease Trial, Recruiting

NCT06203106
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be at least 30 days old.
  • You have been diagnosed with a specific condition, disease, or genetic trait of interest — or you are a healthy person serving as a comparison (control).
  • If you are an adult who can make your own decisions, you must be able to give written consent (unless a physical limitation prevents you from signing).
  • If you are an adult who cannot make your own decisions, you must have one of the following conditions: ALS, Alzheimer's Disease or related dementias, Batten Disease, Corticobasal Degeneration, Dementia, Frontotemporal Dementia, Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy, Parkinson's Disease, Parkinsonism, or Progressive Supranuclear Palsy — and a legal representative must provide written consent on your behalf.
  • Children having a skin sample taken for research must have a relevant condition or genetic trait, and a parent or guardian must give consent.
  • Children having a blood or saliva sample taken may have a relevant condition or serve as a healthy control, and a parent or guardian must be available to give consent.
  • Children contributing previously collected biological samples and related health data may have a relevant condition or serve as a healthy control, and a parent or guardian must be available to give consent.

Who may not be able to join:

  • People who are wards of the state (in government care) are not eligible.
  • If you are providing a skin sample: people with a history of raised/overgrown scar tissue (keloids), a blood clotting disorder, or an allergy to local anesthetic cannot participate.
  • If you are providing a blood sample: people with a history of a blood clotting disorder cannot participate.
  • For any type of sample collection: people who are unwilling to follow the safety rules set by the research organisation or collection site cannot participate.
  • For any type of sample collection: people who have been diagnosed with AIDS and have a very low immune cell count (CD4 count below 200 cells per microliter of blood) cannot participate, due to an increased risk of infection.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Laura Andres-Martin, PhD, New York Stem Cell Foundation Research Institute

Phone: 212-927-1801

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
New York Stem Cell Foundation Research Institute
Registry
ClinicalTrials.gov
Start date
10 November 2022
Est. completion
10 November 2045

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biobank

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov